PT - JOURNAL ARTICLE AU - Du, Yuhui AU - Fu, Zening AU - Sui, Jing AU - Gao, Shuang AU - Xing, Ying AU - Lin, Dongdong AU - Salman, Mustafa AU - Rahaman, Md Abdur AU - Abrol, Anees AU - Chen, Jiayu AU - Hong, L Elliot AU - Kochunov, Peter AU - Osuch, Elizabeth A. AU - Calhoun, Vince D. AU - for the Alzheimer’s Disease Neuroimaging Initiative TI - NeuroMark: an adaptive independent component analysis framework for estimating reproducible and comparable fMRI biomarkers among brain disorders AID - 10.1101/19008631 DP - 2019 Jan 01 TA - medRxiv PG - 19008631 4099 - http://medrxiv.org/content/early/2019/10/16/19008631.short 4100 - http://medrxiv.org/content/early/2019/10/16/19008631.full AB - Increasing data-sharing initiatives have provided unprecedented opportunities to study brain disorders. Standardized approaches for capturing reproducible and comparable biomarkers are greatly needed in big-data analysis. Here, we propose a framework (called NeuroMark) that leverages a priori-driven independent component analysis (ICA) to extract functional brain network features from fMRI data. NeuroMark estimates features adaptable to each individual and comparable across subjects by taking advantage of the replicated brain network templates extracted from 1828 healthy controls. Four studies including 2454 subjects were conducted, spanning six brain disorders (schizophrenia, autism spectrum disorder, depression, bipolar disorder, mild cognitive impairment and Alzheimer’s disease) to evaluate the proposed framework from different perspectives (replication, cross-study comparison, subtle difference identification, and multi-disorder classification). Our results demonstrate the great potential of NeuroMark to identify reproducible and comparable brain network markers, its feasibility to link results across different datasets/studies/disorders, and its sensitivity in identifying biomarkers for patients with challenging mental illnesses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Natural Science Foundation of China (Grant No. 61703253 to YHD, 61773380 to JS), National Institutes of Health grants 5P20RR021938/P20GM103472 &; R01EB020407 and National Science Foundation grant 1539067 (to VDC).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not Applicable2454 subjects were used, spanning six brain disorders (schizophrenia, autism spectrum disorder, depression, bipolar disorder, mild cognitive impairment and Alzheimer’s disease）. We have the agreements for the use of all data.